Published in Mayo Clin Proc on January 01, 2000
For estimating creatinine clearance measuring muscle mass gives better results than those based on demographics. Kidney Int (2009) 2.32
Skeletal muscle protein anabolic response to resistance exercise and essential amino acids is delayed with aging. J Appl Physiol (1985) (2008) 2.20
Attenuation of sarcopenia by dietary restriction in rhesus monkeys. J Gerontol A Biol Sci Med Sci (2008) 2.00
A critical evaluation of chronic kidney disease--should isolated reduced estimated glomerular filtration rate be considered a 'disease'? Nephrol Dial Transplant (2008) 1.70
Aberrant mitochondrial homeostasis in the skeletal muscle of sedentary older adults. PLoS One (2010) 1.58
GFR estimation in Japan and China: what accounts for the difference? Am J Kidney Dis (2009) 1.28
Advantages of dietary, exercise-related, and therapeutic interventions to prevent and treat sarcopenia in adult patients: an update. Clin Interv Aging (2010) 1.17
Skeletal muscle mass is associated with bone geometry and microstructure and serum insulin-like growth factor binding protein-2 levels in adult women and men. J Bone Miner Res (2012) 1.00
Bone strength and structural deficits in children and adolescents with a distal forearm fracture resulting from mild trauma. J Bone Miner Res (2014) 0.99
Target population for clinical trials on sarcopenia. J Nutr Health Aging (2008) 0.92
Development of a practical screening tool to predict low muscle mass using NHANES 1999-2004. J Cachexia Sarcopenia Muscle (2013) 0.90
Amino acid metabolism and regulatory effects in aging. Curr Opin Clin Nutr Metab Care (2008) 0.88
Gender differences in anthropometric predictors of physical performance in older adults. Gend Med (2012) 0.87
Senile nephrosclerosis--does it explain the decline in glomerular filtration rate with aging? Nephron Physiol (2011) 0.85
Risk of Mortality According to Body Mass Index and Body Composition Among Postmenopausal Women. Am J Epidemiol (2015) 0.84
The effect of testosterone and a nutritional supplement on hospital admissions in under-nourished, older people. BMC Geriatr (2011) 0.84
Muscle sympathetic nerve activity during cold stress and isometric exercise in healthy older adults. J Appl Physiol (1985) (2014) 0.81
Diurnal Patterns of Physical Activity in Relation to Activity Induced Energy Expenditure in 52 to 83 Years-Old Adults. PLoS One (2016) 0.75
Treatment with a corticotrophin releasing factor 2 receptor agonist modulates skeletal muscle mass and force production in aged and chronically ill animals. BMC Musculoskelet Disord (2011) 0.75
Anatomic landmarks facilitate predictable partial lower limb loading during aquatic weight bearing. Curr Orthop Pract (2015) 0.75
Involutional osteoporosis. N Engl J Med (1986) 8.20
Perspective. How many women have osteoporosis? J Bone Miner Res (1992) 4.99
Relationship of serum sex steroid levels and bone turnover markers with bone mineral density in men and women: a key role for bioavailable estrogen. J Clin Endocrinol Metab (1998) 4.28
A unitary model for involutional osteoporosis: estrogen deficiency causes both type I and type II osteoporosis in postmenopausal women and contributes to bone loss in aging men. J Bone Miner Res (1998) 4.24
Treatment of postmenopausal osteoporosis with transdermal estrogen. Ann Intern Med (1992) 4.19
beta-Lactamase proceeds via an acyl-enzyme intermediate. Interaction of the Escherichia coli RTEM enzyme with cefoxitin. Biochemistry (1980) 3.94
Effect of the fluoride/calcium regimen on vertebral fracture occurrence in postmenopausal osteoporosis. Comparison with conventional therapy. N Engl J Med (1982) 3.77
Weekend hospitalization and additional risk of death: an analysis of inpatient data. J R Soc Med (2012) 3.77
Differential changes in bone mineral density of the appendicular and axial skeleton with aging: relationship to spinal osteoporosis. J Clin Invest (1981) 3.60
The roles of osteoprotegerin and osteoprotegerin ligand in the paracrine regulation of bone resorption. J Bone Miner Res (2000) 3.38
Epidemiology of vertebral fractures in women. Am J Epidemiol (1989) 3.27
Relative contributions of testosterone and estrogen in regulating bone resorption and formation in normal elderly men. J Clin Invest (2000) 2.94
Epidemiology of fractures of the proximal femur in Rochester, Minnesota. Clin Orthop Relat Res (1981) 2.93
Changes in bone mineral density of the proximal femur and spine with aging. Differences between the postmenopausal and senile osteoporosis syndromes. J Clin Invest (1982) 2.92
Fractures after rheumatoid arthritis. A population-based study. Arthritis Rheum (1984) 2.85
Evidence of estrogen receptors in normal human osteoblast-like cells. Science (1988) 2.85
Epidemiologic features of humeral fractures. Clin Orthop Relat Res (1982) 2.79
Implications of absolute fracture risk assessment for osteoporosis practice guidelines in the USA. Osteoporos Int (2008) 2.74
Cost-effective osteoporosis treatment thresholds: the United States perspective. Osteoporos Int (2008) 2.72
Stimulation of osteoprotegerin ligand and inhibition of osteoprotegerin production by glucocorticoids in human osteoblastic lineage cells: potential paracrine mechanisms of glucocorticoid-induced osteoporosis. Endocrinology (1999) 2.69
Interleukin-1beta and tumor necrosis factor-alpha, but not interleukin-6, stimulate osteoprotegerin ligand gene expression in human osteoblastic cells. Bone (1999) 2.69
Leptin acts on human marrow stromal cells to enhance differentiation to osteoblasts and to inhibit differentiation to adipocytes. Endocrinology (1999) 2.65
Long-term fracture prediction by bone mineral assessed at different skeletal sites. J Bone Miner Res (1993) 2.59
Secular trends in the incidence of hip fractures. Calcif Tissue Int (1987) 2.40
Cancellous bone remodeling in type I (postmenopausal) osteoporosis: quantitative assessment of rates of formation, resorption, and bone loss at tissue and cellular levels. J Bone Miner Res (1990) 2.39
Osteoporosis and the risk of hip fracture. Am J Epidemiol (1986) 2.35
Estrogen stimulates gene expression and protein production of osteoprotegerin in human osteoblastic cells. Endocrinology (1999) 2.27
Idiopathic osteoporosis--is the osteoblast to blame? J Clin Endocrinol Metab (1997) 2.25
Vertebral fractures predict subsequent fractures. Osteoporos Int (1999) 2.24
Intestinal calcium absorption and serum vitamin D metabolites in normal subjects and osteoporotic patients: effect of age and dietary calcium. J Clin Invest (1979) 2.21
Evidence for two distinct syndromes of involutional osteoporosis. Am J Med (1983) 2.17
Incidence of Colles' fracture in a North American community. Am J Public Health (1982) 2.17
Isolation and characterization of osteoblast precursor cells from human bone marrow. J Bone Miner Res (1996) 2.16
Relationship of glucocorticoid dosage to serum bone Gla-protein concentration in patients with rheumatologic disorders. Arthritis Rheum (1990) 2.03
Rates of bone loss in the appendicular and axial skeletons of women. Evidence of substantial vertebral bone loss before menopause. J Clin Invest (1986) 2.01
Risk factors for spinal osteoporosis in men. Am J Med (1983) 2.00
Development and characterization of a conditionally immortalized human fetal osteoblastic cell line. J Bone Miner Res (1995) 1.97
Epidemiology of sarcopenia. J Am Geriatr Soc (2000) 1.97
Skeletal effects of estrogen. Endocr Rev (1994) 1.91
Relative contributions of aging and estrogen deficiency to postmenopausal bone loss. N Engl J Med (1984) 1.90
Identification of a novel TGF-beta-regulated gene encoding a putative zinc finger protein in human osteoblasts. Nucleic Acids Res (1995) 1.89
Classification of vertebral fractures. J Bone Miner Res (1991) 1.89
Role of calcium intake in modulating age-related increases in parathyroid function and bone resorption. J Clin Endocrinol Metab (1996) 1.79
Bone density and fracture risk in men. J Bone Miner Res (1998) 1.77
Comparison of sex steroid measurements in men by immunoassay versus mass spectroscopy and relationships with cortical and trabecular volumetric bone mineral density. Osteoporos Int (2008) 1.73
Prevalence and incidence of vertebral deformities. Osteoporos Int (1993) 1.72
Assessing forearm fracture risk in postmenopausal women. Osteoporos Int (2009) 1.71
Increase in serum bone gamma-carboxyglutamic acid protein with aging in women. Implications for the mechanism of age-related bone loss. J Clin Invest (1983) 1.69
Immunologic differentiation of primary hyperparathyroidism from hyperparathyroidism due to nonparathyroid cancer. J Clin Invest (1971) 1.68
Genomic imprinting in mammals: an interplay between chromatin and DNA methylation? Trends Genet (1999) 1.67
Avian osteoclasts as estrogen target cells. Proc Natl Acad Sci U S A (1991) 1.65
Diagnosis of osteoporosis: usefulness of photon absorptiometry at the radius. J Nucl Med (1977) 1.63
Inhibition of hydroxyapatite crystal growth by bone-specific and other calcium-binding proteins. Biochemistry (1986) 1.57
Relationship between body composition and bone mass in women. J Bone Miner Res (1996) 1.57
DNA methylation is linked to deacetylation of histone H3, but not H4, on the imprinted genes Snrpn and U2af1-rs1. Mol Cell Biol (2001) 1.55
Histomorphometric analysis of iliac crest bone biopsies in placebo-treated versus fluoride-treated subjects. Osteoporos Int (1995) 1.51
Effect of combined therapy with sodium fluoride, vitamin D and calcium in osteoporosis. Am J Med (1972) 1.50
Differential effects of endocrine dysfunction on the axial and the appendicular skeleton. J Clin Invest (1982) 1.48
Differentiation of human marrow stromal precursor cells: bone morphogenetic protein-2 increases OSF2/CBFA1, enhances osteoblast commitment, and inhibits late adipocyte maturation. J Bone Miner Res (1999) 1.44
The expression of osteoprotegerin and RANK ligand and the support of osteoclast formation by stromal-osteoblast lineage cells is developmentally regulated. Endocrinology (2000) 1.43
Bone densitometry and clinical decision-making in osteoporosis. Ann Intern Med (1988) 1.43
Effect of gender on outcomes following renal artery stent placement for renovascular hypertension. Cathet Cardiovasc Diagn (1997) 1.43
Colles' fracture and subsequent hip fracture risk. Clin Orthop Relat Res (1983) 1.43
Radioimmunoassay of parathyroid hormone in hypercalcemic patients with malignant disease. Am J Med (1974) 1.42
Measurement of bone mineral content in human vertebrae and hip by dual photon absorptiometry. Radiology (1980) 1.42
Leptin reduces ovariectomy-induced bone loss in rats. Endocrinology (2001) 1.40
Three-year follow-up on effects of transdermal estrogen. Ann Intern Med (1996) 1.39
Rotational atherectomy for left anterior descending artery septal perforator stenosis. Catheter Cardiovasc Interv (1999) 1.39
Intestinal calcium absorption in exogenous hypercortisonism. Role of 25-hydroxyvitamin D and corticosteroid dose. J Clin Invest (1977) 1.37
Effect of estrogen on calcium absorption and serum vitamin D metabolites in postmenopausal osteoporosis. J Clin Endocrinol Metab (1980) 1.37
Cross-sectional versus longitudinal evaluation of bone loss in men and women. Osteoporos Int (2000) 1.37
Effect of sex hormones on bone in primary osteoporosis. J Clin Invest (1969) 1.36
Survival after the diagnosis of hyperparathyroidism: a population-based study. Am J Med (1998) 1.36
The rise and fall of primary hyperparathyroidism: a population-based study in Rochester, Minnesota, 1965-1992. Ann Intern Med (1997) 1.35
Effects of estrogen therapy on bone marrow adipocytes in postmenopausal osteoporotic women. Osteoporos Int (2008) 1.35
Towards a diagnostic and therapeutic consensus in male osteoporosis. Osteoporos Int (2011) 1.33
Osteoprotegerin production by human osteoblast lineage cells is stimulated by vitamin D, bone morphogenetic protein-2, and cytokines. Biochem Biophys Res Commun (1998) 1.33
Risk factors for injury after a fall. Clin Geriatr Med (1985) 1.33
Correlates of osteoprotegerin levels in women and men. Osteoporos Int (2002) 1.31
Mutation in a gene for type I procollagen (COL1A2) in a woman with postmenopausal osteoporosis: evidence for phenotypic and genotypic overlap with mild osteogenesis imperfecta. Proc Natl Acad Sci U S A (1991) 1.31
Immunoreactive forms of circulating parathyroid hormone in primary and ectopic hyperparathyroidism. J Clin Invest (1974) 1.30
Role of hyperbilirubinemia in the impairment of osteoblast proliferation associated with cholestatic jaundice. J Clin Invest (1995) 1.29
The clinical diagnosis of osteoporosis: a position statement from the National Bone Health Alliance Working Group. Osteoporos Int (2014) 1.27
Fifty-year trend in hip fracture incidence. Clin Orthop Relat Res (1982) 1.26